Investing.com’s stocks of the week Sam Boughedda Fri, October 16, 2026 at 2:23 PM EDT 3 min read NVDA -1.68% MU -5.45% TSLA -3.45% MSTR -11.05% Explore stocks on Coinbase Trading disclosure Trading disclosure The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Investing.com -- An unwind in the AI trade has dominated the week, with debt costs and Chinese competition driving losses across data center and memory names.
Still guessing which stocks will beat the market? Our AI portfolio updates monthly and is outperforming the S&P 500 by 118%. See this month's list »
CoreWeave was at the center of the selloff, plunging 15.5% on Wednesday and falling more than 11% so far on Friday, leaving it down more than 25% across the week.
The declines came as the yield to maturity on the company's debt briefly rose above 16% on Thursday, fueling concern about the cost of funding its data center buildout at a time when inflation has revived rate-hike expectations.
The stock briefly recovered close to 6% on Thursday after Nvidia CEO Jensen Huang told Bloomberg he was optimistic about the company.
Cantor Fitzgerald analyst Brett Knoblauch reiterated an Overweight rating and $176 price target, pointing to "a lot of fearmongering" over recent days and arguing the market is getting it wrong.
He noted that CoreWeave has the public support of Nvidia, has sold out nearly all capacity coming online for 2027, and has an agreement with Nvidia to backstop any unsold capacity.
Memory names were among the hardest hit, with SK Hynix down 19.7% over the week, SanDisk 19.1% lower and Micron off 15.2%.
All three have declined again on Friday, with Micron currently down 3.6%, SK Hynix off 5% and SanDisk 5.3% lower.
The selling followed an October 13 announcement from China's ChangXin Memory Technologies, which disclosed a breakthrough in 4F² DRAM architecture and plans to launch a new data center chip design by year-end.
Unsure what to buy ahead of earnings? Our AI's recent pre-earnings calls delivered gains of +77% to +118% after results dropped. See this month's earnings picks »
Concerns over a potential strike at a key Micron manufacturing facility added further pressure.
UBS analyst Nicolas Gaudois said the correction has created an attractive entry point, maintaining Buy ratings across their coverage.
Tesla opened higher on Friday after unveiling its long-awaited second-generation Roadster at SpaceX's McGregor, Texas facility on Thursday night, but has since reversed, trading down 2.7% and is on course to end the week around 7.8% lower.
JPMorgan analyst Rajat Gupta reiterated a Neutral rating and $415 price target on Tesla, noting the two-seat vehicle incorporates cold-gas thrusters, an advanced underbody suction system and active aerodynamics, enabling controlled aerial maneuvers.
Strategy has tumbled more than 9% so far on Friday and is down 11.2% over the week after MSCI said it will adopt new rules that could exclude the company from its indexes.
Under the methodology, which takes effect with the November index review, MSCI will assess companies using screens for operating assets and five financial ratios, replacing interim restrictions targeting firms with digital asset holdings of at least 50% of total assets.
MSCI previously identified Strategy among the companies that would be deleted under its non-operating companies approach, with Sharplink, Ton Strategy Company, Solana Company and DeFi Development Corp among those placed on a watchlist.
However, Strategy pushed back, with Executive Chairman Michael Saylor and CEO Phong Le calling the proposal "discriminatory" toward digital asset treasury companies. A final list of affected companies is expected on November 11.
Bumble skyrocketed this week, surging more than 130% after an announcement on Tuesday revealed it had agreed to be acquired by Ithaca Holdings in an all-cash deal valuing the company at $1.3 billion.
Shareholders will receive $6.05 per Class A share, a premium of around 138% to the unaffected October 9 closing price and 119% to the 30-day volume-weighted average price.
City Therapeutics surges in market debut after upsizing $200M IPO
European stocks post best week since June on easing yields